Fundraising Fox

Henry Chen

Investor

Managing Partner at Delos Capital

Hong Kong

FoundedCuramir TherapeuticsInstylla IncTulavi Therapeutics

About

Henry Chen founded Delos Capital in 2014 and serves as its Managing Partner. He was previously a Partner and Co-Head of Asia at Permira, and earlier spent nine years at Goldman Sachs as a Managing Director and co-head of the General Industrials Group for Asia (ex-Japan), following corporate finance law work at Davis Polk. He has co-founded Curamir Therapeutics and Tulavi Therapeutics and served as CEO and Chairman of Tanvex BioPharma, and holds bachelor's and master's degrees from Harvard University and a JD from Harvard Law School.

LinkedIn ↗

Experience

  1. Delos CapitalFounder and Managing Partnercurrent2014 — present
  2. Tanvex Biopharma USA, IncChairperson2023 — 2025
  3. Tanvex Biopharma USA, IncChief Executive Officer2023 — 2024
  4. Curamir Therapeutics, Inc.Chief Executive Officer2019 — 2022Woburn, Massachusetts, United States
  5. Tanvex Biopharma USA, IncChief Executive Officer2020 — 2021
  6. Tanvex Biopharma USA, IncChief Financial Officer2020 — 2021
  7. Tanvex Biopharma USA, IncChairman2021
  8. PermiraPartner, Co-head, Asia2008 — 2014Hong Kong
  9. Goldman SachsManaging Director1999 — 2008Hong Kong
  10. Davis Polk & Wardwell LLPAssociate1996 — 1999

Education

  1. Harvard Law SchoolJD1993 — 1996
  2. Harvard UniversityMaster of Arts (M.A.), History of Science1992 — 1993
  3. Harvard UniversityAB, History and Science1989 — 1993

Skills & more

Strategy1Corporate Development6Private Equity15Venture Capital16Mergers & Acquisitions7Valuation3Due Diligence4Emerging Markets2M&A experience1LBO1Capital Markets1Investment Banking6
+2 moreBusiness StrategyInvestments

From Henry's professional profile.

Same school

Also attended Harvard Law School133

Keith RaboisManaging Director at Khosla VenturesKen ChenaultInvestment Team at General CatalystDavid GoldenManaging Partner, Revolution VenturesTracy Van GrackChief Communications Officer at RevolutionSid ShenaiVenture partner at Madrona and co-founder and CEO of Proof DiagnosticsRufus KingInvestor at OpenView Venture Partners

+ 127 more

Also attended Harvard University1,231

Alfred LinPartner at Sequoia CapitalChris DixonFounder & Managing Partner of a16z crypto at Andreessen HorowitzSarah TavelVenture Partner at BenchmarkDanny RimerPartner at Index VenturesLaela SturdyManaging Partner at CapitalGRyan IsonoDeal Partner at Felicis Ventures

+ 1,225 more

Shared employers

Also worked at Permira25

Lauren ArribasInvestor at GreycroftSimon SegarsExecutive Advisor at Black Opal VenturesCarolyn WollAssociate at Volition CapitalLouis SautetPartner at Founders FutureCharlotte HalliseyAssociate at Advance Venture PartnersNelly MarkovaPartner - Molten East at Molten Ventures

+ 19 more

Also worked at Goldman Sachs1,236

Josh KushnerFounder & CEO of Thrive CapitalFred EhrsamCo-founder and Senior Advisor at Paradigm; founder of NudgeMatt HuangCo-founder and Managing Partner at ParadigmNiki PezeshkiGeneral Partner at Felicis VenturesChris BischoffInvestment Team at General CatalystDamir BecirovicInvestor at Index Ventures

+ 1,230 more

Also worked at Davis Polk & Wardwell LLP16

David GoldenManaging Partner, Revolution VenturesSallie KimInvestor at 8VCAndrew WilsonPartner, Legal at Lux CapitalCraig ShermanManaging Director at Service Provider CapitalElizabeth GrahamBoard Member at MassChallenge MexicoFannie ChenChief Operating Officer at 25Madison

+ 10 more

Investments

Board seats

Tanvex BioPharma Inc.

Investor

Curamir Therapeutics Inc.Tulavi Therapeutics

Per the firm's website.

Colleagues at Delos Capital

Agnes Kwok
Financial Controller at Delos Capital
Andrea Lok
Executive Assistant at Delos Capital
Carrie Greenaway
Office Manager at Delos Capital
Eric Huang
Partner at Delos Capital
Hank Huang
Associate at Delos Capital
Lee Cooper
Managing Director at Delos Capital
Paul Shen
Operations Manager at Delos Capital
Tej Pavoor
Partner at Delos Capital